Tarbox Family Office, Inc. Exelixis, Inc. Transaction History

Tarbox Family Office, Inc.

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Jul 19, 2022	BUY	$17.44 - $23.16 $316,972 - $420,933	18,175 New	18,175 $378,000
Q4 2021 Jan 06, 2022	SELL	$15.84 - $21.88 $287,892 - $397,669	-18,175 Closed	0 $0
Q3 2021 Oct 12, 2021	SELL	$16.3 - $21.14 $81,500 - $105,700	-5,000 Reduced 21.57%	18,175 $384,000
Q2 2021 Jul 16, 2021	BUY	$17.95 - $25.56 $415,991 - $592,353	23,175 New	23,175 $422,000

520

244M

2.84M

2.29M

Ticker EXEL
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 321,832,000
Market Cap $10.7B
Description
Exelixis, Inc., an oncology-focused biotechnology company, focuses on the discovery, development, and commercialization of new medicines to treat cancers in the United States. The company's products include CABOMETYX tablets for the treatment of patients with advanced renal cell carcinoma who received prior anti-angiogenic therapy; and COMETRIQ ...

Get notified when there are updates to the investment portfolio of Tarbox Family Office, Inc., based on Form 13F filings with the SEC.

Stay updated on Tarbox Family Office, Inc. with notifications on news.